- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00052130
Vaccine Therapy for Patients With Stage III Melanoma
June 23, 2005 updated by: CancerVax Corporation
Phase III Randomized Double-Blind Pivotal Trial of Immunotherapy With BCG Plus a Polyvalent Melanoma Vaccine, CancerVax™ Vaccine Versus BCG Plus a Placebo as a Post-Surgical Treatment for Stage III Melanoma
This is a Phase 3 study in patients with melanoma that has spread to the lymph nodes (stage III), and who have had all of their cancer surgically removed.
The purpose of this study is to evaluate the ability of the CancerVax™ vaccine to prevent or slow the recurrence of melanoma.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
1118
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New South Wales
-
Sydney, New South Wales, Australia, 2050
- Royal Prince Alfred Hospital, Sydney
-
Westmead, New South Wales, Australia, 2145
- NSW Breast Cancer Institute
-
-
Queensland
-
Brisbane, Queensland, Australia, 4102
- Princess Alexandra Hospital
-
-
South Australia
-
Adelaide, South Australia, Australia, 5000
- Royal Adelaide Hospital
-
-
Victoria
-
Melbourne, Victoria, Australia, 3181
- The Alfred Hospital
-
Melbourne, Victoria, Australia, 3002
- Peter MacCallum Cancer Center
-
-
-
-
-
Rio de Janeiro, Brazil, 20230
- INCA (National Cancer Institute)
-
Sao Paulo, Brazil, 01308-050
- Hospital Sirio Lebanes
-
-
-
-
Quebec
-
Montreal, Quebec, Canada
- McGill University
-
-
-
-
-
Paris, France, 75651
- CHU Pitié-Salpêtrière
-
-
-
-
-
Augsburg, Germany
- Klinikum Augsburg
-
Berlin, Germany
- Charite- University Medicine
-
Jena, Germany
- University of Jena
-
Mannheim, Germany
- University Hospial of Mannheim
-
Tuebingen, Germany
- University of Tuebingen
-
Ulm, Germany
- University of Ulm
-
Wuerzburg, Germany
- University Hospital Wuerzburg
-
-
-
-
-
Cork, Ireland
- Cork University
-
-
-
-
-
Tel Aviv, Israel, 62995
- Tel-Aviv Medical Center
-
-
-
-
-
Milan, Italy, 20133
- Istituto Nazionale Tumori di Milano
-
Milan, Italy, 20141
- Instituto Eurepeo di Oncologia
-
Naples, Italy, 80132
- Istituto Nazionale dei Tumori
-
-
-
-
-
Groningen, Netherlands
- University Hospital of Groningen
-
-
-
-
-
Auckland, New Zealand, 92024
- North Shore Hospital
-
-
-
-
-
Zurich, Switzerland
- University of Zurich
-
-
-
-
England
-
London, England, United Kingdom, SW17 ORE
- St. Georges Hospital Medical School
-
-
-
-
Arizona
-
Tucson, Arizona, United States, 85724
- Arizona Cancer Center
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- University of Arkansas for Medical Sciences
-
Little Rock, Arkansas, United States, 72205
- Central Arkansas Veterans Healthcare System
-
-
California
-
Anaheim, California, United States
- Kaiser Permanente Medical Group
-
Los Angeles, California, United States
- Cedars Sinai Comprehensive Cancer Center
-
Newport Beach, California, United States, 92658
- HOAG Memorial Hospital Presbyterian
-
Palm Springs, California, United States, 92262
- Comprehensive Cancer Center at DRMC
-
Riverside, California, United States
- Kaiser Permanente Medical Group
-
San Diego, California, United States, 92120
- Kaiser Permanente Medical Group
-
San Diego, California, United States, 92123
- Sharp Hospital
-
San Francisco, California, United States, 94143-0128
- UCSF Cancer Center and Cancer Research Institute
-
-
Colorado
-
Aurora, Colorado, United States
- University of Colorado Cancer Center
-
-
Florida
-
Lakeland, Florida, United States, 33805
- Lakeland Regional Cancer Center
-
Miami, Florida, United States
- University of Miami
-
Miami, Florida, United States
- Mt. Sinai Comprehensive Cancer Center
-
Orlando, Florida, United States, 32804
- Florida Hospital Cancer Institute
-
Tampa, Florida, United States, 33612-9497
- H. Lee Moffitt Cancer Center and Research Institute
-
West Palm Beach, Florida, United States, 33401
- The Cancer Institute at Good Samaritan Medical Center
-
-
Georgia
-
Atlanta, Georgia, United States, 30322
- Winship Cancer Institute at Emory University
-
-
Illinois
-
Maywood, Illinois, United States
- Loyola University Medical Center
-
Peoria, Illinois, United States, 61637
- OSF Saint Francis Medica Center
-
-
Indiana
-
Bloomington, Indiana, United States, 47402
- Cancer Care of Southern Indiana
-
Indianapolis, Indiana, United States, 46256
- Wagner and Associates
-
-
Kentucky
-
Louisville, Kentucky, United States, 40202
- James Graham Brown Cancer Center
-
-
Maryland
-
Baltimore, Maryland, United States, 21237
- Franklin Square Hospital Center
-
Baltimore, Maryland, United States, 21229
- St. Agnes Healthcare
-
Lutherville, Maryland, United States
- Sidney Kimmel Comprehensive Cancer Center
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118-2393
- Boston Medical Center
-
-
Michigan
-
Ann Arbor, Michigan, United States
- University of Michigan Medical Center
-
Grand Rapids, Michigan, United States, 49546
- Spectrum Health - Butterworth Campus
-
-
Missouri
-
Columbia, Missouri, United States, 65203
- Ellis Fischel Cancer Center - Columbia
-
Saint Louis, Missouri, United States, 63110-0250
- St. Louis University Health Sciences Center
-
-
New Jersey
-
Hackensack, New Jersey, United States, 07601
- The Cancer Cener at Hackensack University Medical Center
-
Princeton, New Jersey, United States, 08540
- Medical Center of Princeton
-
-
New York
-
Buffalo, New York, United States, 14263-0001
- Roswell Park Cancer Institute
-
Buffalo, New York, United States, 14209
- Millard Fillmore Hospital
-
New York, New York, United States, 10032
- Columbia Presbyterian Medical Center
-
Syracuse, New York, United States, 13210
- Suny Health Science Center at Syracuse
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599-7295
- Lineberger Comprehensive Cancer Center, UNC
-
-
Ohio
-
Cincinnati, Ohio, United States, 45219
- Christ Hospital
-
Cleveland, Ohio, United States
- Cleveland Clinic Foundation
-
Columbus, Ohio, United States, 43210-1240
- Arthur G. James Cancer Hospital - Ohio State University
-
Dayton, Ohio, United States, 45409
- Dayton Clinical Oncology Group
-
-
Pennsylvania
-
Bethlehem, Pennsylvania, United States, 18015
- St. Lukes Hospital Cancer Center
-
Philadelphia, Pennsylvania, United States, 19111
- Fox Chase Cancer Center
-
Philadelphia, Pennsylvania, United States, 19104-4283
- University of Pennsylvania Cancer Center
-
Wynnewood, Pennsylvania, United States, 19096
- Lankenau Hospital
-
-
Tennessee
-
Nashville, Tennessee, United States, 37232-6838
- Vanderbilt-Ingram Cancer Center
-
-
Texas
-
Dallas, Texas, United States, 75235-9154
- UT Southwest Medical Center- Dallas
-
Houston, Texas, United States, 77030-4009
- University of Texas - MD Anderson Cancer Center
-
-
Utah
-
Ogden, Utah, United States, 84403
- Intermountain Health Care- Mckay-Dee Hospital
-
Salt Lake City, Utah, United States, 84143
- Intermountain Health Care-LDS Hospital
-
-
Washington
-
Seattle, Washington, United States, 98195
- University of Washington
-
Tacoma, Washington, United States, 98405
- Northwest Medical Specialties
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
- Must have Stage III melanoma
- Must have had all clinically-detectable disease surgically removed
- Cannot be taking any medications, or undergoing any therapies which compromise the functioning of your immune system (ie. Some corticosteroids, and certain types of radiation therapy)
- Cannot have HIV or Hepatitis A, B, or C
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
January 22, 2003
First Submitted That Met QC Criteria
January 23, 2003
First Posted (Estimate)
January 24, 2003
Study Record Updates
Last Update Posted (Estimate)
June 24, 2005
Last Update Submitted That Met QC Criteria
June 23, 2005
Last Verified
September 1, 2004
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CV-MMAIT-3-001
- JWCI-MC-3-001A
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Malignant Melanoma
-
National Cancer Institute (NCI)TerminatedRecurrent Melanoma | Stage IV Melanoma | Acral Lentiginous Malignant Melanoma | Lentigo Maligna Malignant Melanoma | Nodular Malignant Melanoma | Solar Radiation-related Skin Melanoma | Superficial Spreading Malignant MelanomaUnited States
-
Grupo Español Multidisciplinar de MelanomaGlaxoSmithKlineCompletedMalignant Melanoma Stage IV | Malignant Melanoma Stage IIIcSpain
-
Centre Hospitalier Universitaire de NiceUnknownMalignant Melanoma Stage III | Malignant Melanoma Stage IV
-
Hoffmann-La RocheCompletedMalignant Melanoma, CancerHungary
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsUnited States, South Africa, Croatia, Brazil, Egypt
-
Lynn E. Spitler, MDGenentech, Inc.; Celgene CorporationCompletedMetastatic Malignant MelanomaUnited States
-
National Cancer Institute (NCI)GlaxoSmithKline; Novartis PharmaceuticalsActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Metastatic Melanoma | Stage IV Cutaneous Melanoma AJCC v6 and v7 | Locally Advanced Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Locally Advanced Melanoma | Metastatic Malignant Solid Neoplasm | Stage IIIC Cutaneous Melanoma AJCC v7 | Unresectable...United States
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsKorea, Republic of, Brazil, United States, Canada, Cyprus
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Steinar AamdalTerminatedMetastatic Malignant MelanomaNorway
Clinical Trials on CancerVax vaccine (CANVAXIN)
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Butantan InstituteUniversity of Sao Paulo; Hospital Universitario da USPCompleted
-
Sinovac Biotech Co., LtdCompleted
-
GlaxoSmithKlineCompletedMalaria | Malaria VaccinesGhana, Burkina Faso
-
University of OxfordMalaria Research and Training Center, Bamako, MaliRecruiting
-
GlaxoSmithKlineIQVIA, USAActive, not recruitingChickenpoxTaiwan, Poland, United States, Estonia, Puerto Rico, Mexico
-
Sun XinActive, not recruitingVaccine Adverse ReactionChina
-
GlaxoSmithKlineCompletedInfections, PapillomavirusFinland
-
University of California, San FranciscoCompletedHematopoietic Stem Cell TransplantUnited States
-
University of PretoriaUniversity of StellenboschActive, not recruiting